Poncz M, Newman P J
Division of Hematology, Children's Hospital of Philadelphia, PA 19104.
Blood. 1990 Mar 15;75(6):1282-9.
Recently, the full-length primary amino acid sequence for human glycoproteins (GP) IIb and IIIa have been derived from their respective cDNAs. Potential functional domains within these proteins have been proposed based primarily on homology with similar domains in other proteins having known biologic function. To further understand the relationship between structure and function of the platelet fibrinogen receptor, we have begun comparative studies of the human GPIIb/IIIa receptor with the corresponding rodent receptor. The rodent rGPIIb/IIIa receptor differs from the human receptor, having low affinity for R.G.D-containing oligopeptides and not binding at all to the C-terminus of the gamma chain of human fibrinogen. We describe the structure of rodent platelet GPIIb derived from a combination of peptide sequencing, and cDNA and partial genomic DNA sequence analysis. The initial transcript is 1037 amino acid residues, having 78% amino acid identity with its 1039 residue human analog. Both heavy chains have the N-terminal sequence L.N.L.D, agreeing with the consensus derived from other integrin family alpha heavy chains. All 18 cysteine residues occur at positions conserved in human GPIIb and the vitronectin receptor alpha subunit VNR alpha. The putative calcium-binding domains of the GPIIbs have a high level of amino acid identity (92%), supporting the supposition that these regions have a critical biologic role. The final 48 C-terminal amino acid residues of the heavy chain of rodent GPIIb share only 56% identity with its human counterpart, and the proposed cleavage site of human GPIIb into its heavy and light chains is not present in the rodent sequence. Although we demonstrate that rodent GPIIb is split into two subunits during its maturation, this process either involves a different recognition sequence in the rodent or occurs at a different site. Finally, partial genomic DNA sequence analysis indicates that there are at least two rodent GPIIb genes: a normal gene, containing introns in positions similar to those in the human gene, and a processed pseudogene. The human haploid genome contains only a single GPIIb gene.
最近,已从人糖蛋白(GP)IIb和IIIa各自的cDNA中获得了它们完整的一级氨基酸序列。这些蛋白质中潜在的功能结构域主要是基于与其他具有已知生物学功能的蛋白质中相似结构域的同源性而提出的。为了进一步了解血小板纤维蛋白原受体的结构与功能之间的关系,我们已开始对人GPIIb/IIIa受体与相应的啮齿动物受体进行比较研究。啮齿动物的rGPIIb/IIIa受体与人受体不同,对含R.G.D的寡肽亲和力低,并且根本不与人纤维蛋白原γ链的C末端结合。我们描述了通过肽测序、cDNA和部分基因组DNA序列分析相结合得出的啮齿动物血小板GPIIb的结构。最初的转录本有1037个氨基酸残基,与其1039个残基的人同源物有78%的氨基酸同一性。两条重链的N末端序列均为L.N.L.D,与其他整合素家族α重链得出的共有序列一致。所有18个半胱氨酸残基都出现在人GPIIb和玻连蛋白受体α亚基VNRα中保守的位置。GPIIb假定的钙结合结构域有高度的氨基酸同一性(92%),支持了这些区域具有关键生物学作用的推测。啮齿动物GPIIb重链的最后48个C末端氨基酸残基与其人对应物仅具有56%的同一性,并且人GPIIb重链和轻链的假定切割位点在啮齿动物序列中不存在。尽管我们证明啮齿动物GPIIb在成熟过程中被分裂成两个亚基,但这个过程要么涉及啮齿动物中不同的识别序列,要么发生在不同的位点。最后,部分基因组DNA序列分析表明至少有两个啮齿动物GPIIb基因:一个正常基因,其内含子位置与人基因中的相似;还有一个加工过的假基因。人类单倍体基因组仅包含一个GPIIb基因。